Coleman JS, Katz E, Menzel H. The diffusion of an innovation among physicians. Sociometry.1957;20:253-270.
Rogers EM. Diffusion of Innovations. New York, NY: Free Press; 1962.
Greer AL. The state of the art versus the state of the science: the diffusion
of new medical technologies into practice. Int J Technol Assess Health Care.1988;4:5-26.
Lomas J, Enkin M, Anderson GM, Hannah WJ, Vayda E, Singer J. Opinion leaders vs audit and feedback to implement practice guidelines:
delivery after previous cesarean section. JAMA.1991;265:2202-2207.
Hiss RG, MacDonald R, David WR. Identification of physician educational influentials in small community
hospitals. Res Med Educ.1978;17:283-288.
Greco PJ, Eisenberg JM. Changing physicians' practices. N Engl J Med.1993;329:1271-1274.
Stross JK, Bole GG. Evaluation of a continuing education program in rheumatoid arthritis. Arthritis Rheum.1980;23:846-849.
Stross JK, Hiss RG, Watts CM, Davis WK, McDonald R. Continuing education in pulmonary disease for primary care physicians. Am Rev Respir Dis.1983;127:739-746.
Collins R, Peto R, Baigent C, Sleight P. Aspirin, heparin, and fibrinolytic therapy in suspected acute myocardial
infarction. N Engl J Med.1997;336:847-860.
American Heart Association. 1997 Heart and Stroke Statistical Update. Dallas, Tex: American Heart Association; 1996.
Yusuf S, Peto R, Lewis J, Collins R, Sleight P. Beta blockade during and after myocardial infarction: an overview of
the randomized trials. Prog Cardiovasc Dis.1985;27:335-371.
Yusuf S, Sleight P, Held P, McMahon S. Routine medical management of acute myocardial infarction Lessons from overviews of recent randomized controlled trials. Circulation.1990;82(3 Suppl):II117-II134.
ISIS-1 (First International Study of Infarct Survival) Collaborative
Group. Randomised trial of intravenous atenolol among 16,027 cases of suspected
acute myocardial infarction: ISIS-1. Lancet.1986;2:57-65.
ISIS-2 (Second International Study of Infarct Survival) Collaborative
Group. Randomised trial of intravenous streptokinase, oral aspirin, both or
neither among 17,187 cases of suspected acute myocardial infarction: ISIS-2. Lancet.1988;2:349-360.
Gurwitz JH, Goldberg RJ, Gore JM. Coronary thrombolysis for the elderly. JAMA.1991;265:1720-1723.
Jansen RWMM, Gurwitz JH. Controversies surrounding the use of beta-blockers in older patients
with cardiovascular disease. Drugs Aging.1994;4:175-183.
ACC/AHA Task Force. Guidelines for the early management of patients with acute myocardial
infarction. J Am Coll Cardiol.1990;16:249-292.
Ryan TJ, Anderson JL, Antman EM.
et al. ACC/AHA guidelines for the management of patients with acute myocardial
infarction. J Am Coll Cardiol.1996;28:1328-1428.
Hine LK, Laird N, Hewitt P, Chalmers T. Meta-analytic evidence against prophylactic use of lidocaine in acute
myocardial infarction. Arch Intern Med.1989;149:2694-2698.
Ellerbeck EF, Jencks SF, Radford MJ.
et al. Quality of care for Medicare patients with acute myocardial infarction. JAMA.1995;273:1509-1514.
McLaughlin TJ, Soumerai SB, Willison D.
et al. Adherence to national guidelines for drug treatment of suspected acute
myocardial infarction: evidence for undertreatment in women and the elderly. Arch Intern Med.1996;156:799-805.
McLaughlin TJ, Soumerai SB, Willison DJ.
et al. The effect of comorbidity on use of thrombolysis or aspirin in patients
with acute myocardial infarction eligible for treatment. J Gen Intern Med.1997;12:1-6.
Gurwitz J, McLaughlin TJ, Willison DJ.
et al. Delayed hospital presentation in patients who have had acute myocardial
infarction. Ann Intern Med.1997;126:593-599.
Greenfield S, Apolone G, McNeil BJ, Cleary PD. The importance of coexistent disease in the occurrence of postoperative
complications and one-year recovery in patients undergoing total hip replacement. Med Care.1993;31:141-154.
Healthcare Education and Research Foundation. Practice Guidelines and Recommendations for Management of Patients
With Uncomplicated Myocardial Infarction. St Paul, Minn: Healthcare Education and Research Foundation; 1991.
Soumerai SB, Avorn JA. Efficacy and cost-containment in hospital pharmacotherapy: state of
the art and future directions. Milbank Mem Fund Q Health Soc.1984;62:447-474.
Soumerai SB, Lipton HL. Evaluating and improving physician prescribing. In: Strom BL, ed. Pharmacoepidemiology. 2nd ed. Chicester,
England: John Wiley & Sons Inc; 1994:395-412.
Soumerai SB, McLaughlin TJ, Avorn JA. Improving drug prescribing in primary care: a critical analysis of
the experimental literature. Milbank Q.1989;67:268-317.
Soumerai SB, Avorn JA. Principles of educational outreach ("academic detailing") to improve
clinical decision making. JAMA.1990;263:549-556.
Armitage P, Berry G. Statistical Methods in Medical Research. 3rd ed. Oxford, England: Blackwell Scientific Publications; 1994:453-458.
Willison DJ, Soumerai SB, McLaughlin TJ.
et al. Consultation between cardiologists and generalists in the management
of acute myocardial infarction. Arch Intern Med.1998;158:1778-1883.
Blumenthal D. Quality of care, 1: what is it? N Engl J Med.1996;335:891-894.
Angell M, Kassirer JP. Quality and the medical marketplace—following elephants. N Engl J Med.1996;335:883-885.
Brook RH, McGlynn EA, Cleary PD. Quality of health care, 2: measuring quality of care. N Engl J Med.1996;335:966-970.
Chassin MR. Quality of health care, 3: improving the quality of care. N Engl J Med.1996;335:1060-1063.
Blumenthal D. Quality of health care, 4: the origins of the quality-of-care debate. N Engl J Med.1996;335:1146-1149.
Berwick DM. Quality of health care, 5: payment by capitation and the quality of
care. N Engl J Med.1996;335:1227-1231.
Davis DA, Thomson MA, Oxman AD, Haynes RB. Changing physician performance: a systematic review of the effect of
continuing medical education strategies. JAMA.1995;274:700-705.
Krumholz HM, Murillo JE, Chen J.
et al. Thrombolytic therapy for eligible elderly patients with acute myocardial
Pashos CL, Normand SLT, Garfinkle JB.
et al. Trends in the use of drug therapies in patients with acute myocardial
infarction: 1988 to 1992. J Am Coll Cardiol.1994;23:1023-1030.
Grilli R, Lomas J. Evaluating the message: the relationship between compliance rate and
the subject of a practice guideline. Med Care.1994;32:202-213.
Lau, J, Antman EM, Jimeniz-Silva J, Kupelnick B, Mosteller F, Chalmers TC. Cumulative meta-analysis of randomized control trials and recommendations
of clinical experts: treatments for myocardial infarction. N Engl J Med.1992;327:248-254.
Tversky A, Kahneman D. Judgement under uncertainty: heuristics and biases. Science.1984;185:1124-1131.
Gurwitz JH, Goldberg RJ. Coronary thrombolysis for the elderly. Is clinical practice really
lagging behind evidence of benefit? JAMA.1997:277:1723-1724.